Article

Agreement announced: InSite Vision to help find test for PCG detection

Alameda, CA-InSite Vision Inc. has joined forces with an unnamed diagnostics company to develop a commercial assay to detect genetic mutations associated with primary congenital glaucoma (PCG).

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) CCOI sets the stage for global ophthalmic innovation at Stanford Summit on July 23
(Image credit: Ophthalmology Times) Accelerating eye health innovation through CCOI – Stanford Summit
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
© 2025 MJH Life Sciences

All rights reserved.